Navigation Links
UCI researchers create new strategy for highly-selective chemotherapy delivery
Date:9/24/2009

Irvine, Calif. UC Irvine researchers have created a new approach that vastly improves the targeting of chemotherapeutic drugs to specific cells and organs.

Kenneth Longmuir, associate professor of physiology & biophysics, and Richard Robertson, professor of anatomy & neurobiology, used liposomes, small spheres (less-than 100 nanometer in diameter) of naturally-occurring lipid molecules, as "packages" for the cancer chemotherapeutic agent doxorubicin, and a small peptide molecule to "address" the package to the targeted tissue.

Using this technology, the research team demonstrated that the doxorubicin was directed almost entirely to the targeted site with virtually no uptake by other organs, including lung, kidney and heart.

Their study appears online in the International Journal of Pharmaceutics.

Their approach is based on the fact that all tissues and organs, including all tumors, are surrounded by a dense region of sugar-containing molecules called polysaccharides. Most importantly, the particular chemical composition of the polysaccharides is different in each tissue and organ of the body. The chemical compositions of the polysaccharides of tumor regions are also different from normal tissue.

The research team developed a nanocarrier system that can recognize specific types of polysaccharide, and has demonstrated effective, organ-specific delivery of nanocarriers, and their therapeutic contents, based upon this polysaccharide-targeting approach.

In their study, the researchers used a peptide derived from a protein found in the microorganism Plasmodium, which is an organism well-known for its exceptional ability to exclusively target the polysaccharides of liver following entry into the bloodstream.

The drug doxorubicin is a chemotherapeutic agent commonly used as treatment for a variety of cancers. Although it is an effective anti-cancer agent, the usefulness of doxorubicin is compromised by its serious side effects on normal tissue. When administered in a chemotherapeutic regimen, doxorubicin distributes widely in the body, including the heart, rather than specifically in tumor regions.

The serious heart damage that results from systemic administration places limits on the dosage that a patient can receive. By encapsulating doxorubicin into a liposome package and including a peptide targeting message on the carrier, Longmuir, Robertson and co-workers demonstrated that doxorubicin can be effectively delivered to the liver, and away from the heart, with a specificity of greater than 100:1.

The next step in this investigation is to test the properties of the delivery system in several experimental cancer models. Liposomes with peptides are being developed that specifically address the unique features of tumors, in order to rapidly and effectively deliver chemotherapeutic agents to tumor regions.


'/>"/>

Contact: Tom Vasich
tmvasich@uci.edu
949-824-6455
University of California - Irvine
Source:Eurekalert

Related medicine news :

1. Pancreatic cancer: Researchers find drug that reverses resistance to chemotherapy
2. VA Honors Eye Researchers With Olin Teague Award
3. Researchers find drug-eluting stents safe, effective for PCI in diabetics
4. Researchers Propose Improved Cervical Cancer Screening
5. Researchers Perfect the View of Heart Disease
6. Mayo Clinic researchers lead national trial testing new treatment for chronic, severe indigestion
7. Indiana U medical researchers boost research and jobs with stimulus legislation grants
8. Canadian researchers discover the first-ever link between intelligence and curiosity
9. MUSC Researchers Concerned About Online Drug Availability
10. UCLA researchers develop biomarker for rapid relief of major depression
11. UCSB researchers develop drug delivery system using nanoparticles and lasers
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/23/2017)... ... July 23, 2017 , ... A 20-year-long study by a ... by the Minneapolis Veterans Administration Health Care System overwhelmingly supports growing evidence that prostate ... few benefits. , In the cases involved with this study, surgery did not ...
(Date:7/23/2017)... LA (PRWEB) , ... July 23, 2017 , ... ... to interact, thus improving communication, safety and patient-provider relationships. New tools are helping ... to results of the 19th Annual Health Care’s Most Wired® survey, released today ...
(Date:7/23/2017)... ... July 23, 2017 , ... Viora Ltd., a leading medical ... No. 9,038,640 by the United States Patent and Trademark Office. The patent applies ... Switching, Vacuum, and Cooling mechanisms to further increase the efficacy and safety of ...
(Date:7/21/2017)... ... ... "As a doctor of lung medicine managing chest diseases for more than two ... inventor from Center Valley, Pa. "My idea is to improve the device to a ... PLEURAL SAFE-t-STAT CATHETER KIT to offer an efficient means of draining pleural fluid from ...
(Date:7/21/2017)... , ... July 21, 2017 , ... ... assistance and financial planning services to families and business owners in northern Florida, ... that promises to provide support to area adults with developmental challenges. , The ...
Breaking Medicine News(10 mins):
(Date:7/5/2017)... BOTHELL, Wash. , July 5, 2017   ... a leading developer, manufacturer and marketer of proprietary clinical ... cryopreservation freeze media ("BioLife"), today announced that ... ("WAVI") its debt holder and largest shareholder, to modify ... Pursuant to the modification, WAVI agreed to ...
(Date:6/30/2017)... 2017  AVACEN Medical (AVACEN) announced the publication of new research ... use of its AVACEN Treatment Method to significantly reduce ... ... Medical ... It affects approximately 200 to 400 million people worldwide according to ...
(Date:6/27/2017)... --  NuEyes (NuEyes Technologies Inc.) today announced that it ... in helping the legally blind live more independent lives. NuEyes works ... developer of augmented, virtual and mixed reality smartglasses and the ... funding amount was provided by strategic partners as well as ... Abu Dhabi , New York ...
Breaking Medicine Technology: